Dr. Hinrich Abken is Professor for Genetics & Immunology at CMMC (Center for Molecular Medicine Cologne) at the University of Cologne and Dept of Internal Medicine, Oncologyâ€Hematology at the University Hospital Cologne where he is working towards the development of adoptive cell therapy of malignant diseases using engineered T-cells. Dr. Abken's group is internationally leading in preâ€clinical research of adoptive therapy with T-cells engineered with chimeric antigen receptors.
preâ€clinical research of adoptive therapy with T-cells engineered with chimeric antigen receptors.